Skip to main content

Maria Martell Pérez-Alcalde

I am a senior researcher, PhD in Biology, coordinator of the Advanced Chronic Liver Disease Laboratory of the Liver Diseases Research Group at the Vall d'Hebron Institut of Research Hospital Research Institute (VHIR).

Institutions of which they are part

Main researcher
Liver Diseases
Vall Hebron Institut de Recerca
Hepatologia
General Hospital

Maria Martell Pérez-Alcalde

Institutions of which they are part

Main researcher
Liver Diseases
Vall Hebron Institut de Recerca
Hepatologia
General Hospital

I am a senior researcher, PhD in Biology, coordinator of the Advanced Chronic Liver Disease Laboratory of the Liver Diseases Research Group at the Vall d'Hebron Institut of Research Hospital Research Institute (VHIR).

I am a senior researcher, PhD in Biology, coordinator of the Advanced Chronic Liver Disease Laboratory of the Liver Diseases Research Group at the Vall d'Hebron Institut of Research Hospital Research Institute (VHIR).

Projects

ADQUISICIÓN DE UN MICROSCOPIO CONFOCAL ESPECTRAL DE RASTREO DE ALTA RESOLUCIÓN DESTINADO A LA PLATAFORMA DE MICROSCOPÍA DE LA UNIDAD DE ALTA TECNOLOGÍA (UAT)

IP: Inmaculada Fuentes Camps
Collaborators: Miquel Vila Bover, Anna Meseguer Navarro, José García Arumí, Joan Gavaldà Santapau, Miguel Segura Ginard, Maria Nieves Martell Pérez-Alcalde, Victor Franco Puntes, Anna Santamaria Margalef, Carmen Espejo Ruiz, María José Buzón Gómez, Javier Inserte Igual, Anna Rosell Novel, Eduardo Fidel Tizzano, Trond Aasen
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 502000
Reference: EQC2019-006247-P
Duration: 01/01/2019 - 31/12/2020

Ministerio de Ciencia

BIODEGRADABLE NANOPARTICLES OF SIMVASTATIN AS NEW THERAPEUTIC TOOL FOR CHRONIC LIVER DISEASE (NANOSIM)

IP: Joan Genescà Ferrer
Collaborators: Maria Nieves Martell Pérez-Alcalde, Diana Fernandes de Rafael
Funding agency: Instituto de Salud Carlos III
Funding: 199946.45
Reference: AC18/00033
Duration: 01/01/2019 - 31/12/2022

NANOPARTICULAS BIODEGRADABLES DE SIMVASTATINA COMO NUEVA HERRAMIENTA TERAPÉUTICA PARA LA ENFERMEDAD HEPÁTICA CRÓNICA

IP: Maria Nieves Martell Pérez-Alcalde
Collaborators: Immaculada Raurell Saborit, Ester Palacio Gutierrez
Funding agency: Instituto de Salud Carlos III
Funding: 75020
Reference: PI17/00754
Duration: 01/01/2018 - 31/12/2020

Malalties Hepatobiliars (GRC)

IP: -
Collaborators: Beatriz Minguez Rosique, Immaculada Raurell Saborit, Lluís Viladomiu Catà, Antonio González Fernández, Lluis Castells Fusté, Maria del Mar Riveiro Barciela, Silvia Sauleda Oliveras, Maria Buti Ferret, Josep Quer Sivila, Josep Gregori Font, Maria Nieves Martell Pérez-Alcalde, Damir Garcia Cehic, Juan Ignacio Esteban Mur, Meritxell Ventura Cots, Macarena Simon-Talero Horga, Joan Genescà Ferrer, David Tabernero Caellas
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 65000
Reference: 2014 SGR 421
Duration: 01/01/2014 - 31/12/2016

Related news

Using computed tomography (CT), with or without contrast, it is possible to perform an accurate and safe detection of the disease without the need for biopsies and avoiding the limitations of other non-invasive diagnostic tools.

On World Clinical Trials Day, we highlight some of the studies we have participated in that confirm the efficacy of new drugs, allowing their approval by regulatory agencies.

Preliminary study results confirm that the drug resmetirom reduces the presence of fat, inflammation, cell damage and fibrosis in the liver.

Related professionals

Vicenta Pujol Blaya

Vicenta Pujol Blaya

Predoctoral researcher
Research Group of Physical Medicine and Rehabilitation
Read more
Cristina Salon Ajenjo

Cristina Salon Ajenjo

Read more
Juan A. Porcel Vázquez

Juan A. Porcel Vázquez

Predoctoral researcher
Reconstructive Surgery of the Locomotor System
Read more
Marina Hortola Bufi

Marina Hortola Bufi

Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.